Wells Fargo raised the firm’s price target on Edgewell Personal Care (EPC) to $22 from $20 and keeps an Overweight rating on the shares. Edgewell is cheap and the portfolio is much improved following the divestiture of the Feminine Care business, the firm says. This is why Wells stays Overweight and raises its target at a higher price to earnings, balanced by still needed visibility into an expected ramp in the second half of 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EPC:
- Edgewell Personal Care price target raised to $21 from $19 at Barclays
- Edgewell Personal Care Affirms No Material Changes to 2025 Risk Profile Disclosures
- Edgewell Personal Care Bets on Back-Half Turnaround
- Edgewell Reaffirms Outlook After Feminine Care Divestiture
- Edgewell Personal Care sees FY26 adjusted EPS $1.70-$2.10, consensus $2.34
